Article Text

Download PDFPDF
Chitinases, neuroinflammation and biomarkers in ALS
  1. Michael Swash
  1. Barts and the London School of Medicine, QMUL, The Royal London Hospital, London E1 1FR, UK
  1. Correspondence to Professor Michael Swash, The Royal London Hospital, London E1 1FR, UK; mswash{at}btinternet.com

Statistics from Altmetric.com

Neuro-inflammatory biomarkers in ALS imply glial pathology

CSF chitinase (Chit-1) and phosphorylated neurofilament heavy chain levels are both raised in patients with amyotrophic lateral sclerosis (ALS), tweaking interest in these proteins as potential disease biomarkers,1 2 for example, in selecting patients for clinical trials. Here, Vu et al 3 show that elevated CSF chitinase levels delineate a subset of fast-progressing ALS. However, although these abnormalities are markers of active disease, they do not change over time and, like other potential biomarkers, they are not specific for ALS. Unlike insects, chitin is not a constituent of mammalian neural or other …

View Full Text

Footnotes

  • Contributors I am the sole contributor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles